CELL CARE

THERAPEUTICS

IN THE NEWS

Cell Care Therapeutics is a Los Angeles based preclinical stage company developing regenerative immunotherapies. This new class of biologics is derived from the secretions of adult stem cells and is comprised of a complex mixture of naturally therapeutic components including proteins, exosomes, and microRNAs. Cell Care has formed a strong team of internal scientists, world class advisors, and manufacturing experts to advance this technology into the clinic. The company is currently developing this technology to treat severe inflammatory and degenerative eye diseases that may lead to vision loss.

REGENERATIVE

IMMUNOTHERAPY

FOR RETINAL DISEASE

THE PLATFORM

Cell free is the way to be

It is increasingly recognized that the predominant therapeutic qualities of adult stem cells come from the secretome, rather than from the cells themselves. Thus, the secretome may be employed to harness the healing properties of stem cells rather than using the cells themselves as the therapy. Cell Care’s off-the-shelf secretome product is an improvement from first-generation living stem cell transplant approaches that can be costly to patients, difficult to dose, routinely lose viability during shipping and after transplantation, can migrate away from the injection site, and are not available off-the-shelf.

 

Cell Care’s technology will allow for the treatment of many degenerative diseases to reduce inflammation, permit recovery, and promote regeneration. The company’s next-generation regenerative therapy will broaden the clinical applicability of regenerative medicine and expand patient access to these new treatment approaches.

Focused on the treatment of degenerative retinal diseases

Cell Care's biologic harnesses the patient's immune system to drive the resolution of the inflammatory process and initiates tissue remodeling leading to the stabilization and recovery of retinal neurovascular tissue.

CONTACT US

info@cell-care.com

750 Royal Oaks Dr. Suite 106

Monrovia, CA

FOLLOW US

© Cell Care Therapeutics.